Xiaoya Yang, Gengyin Wang. Advances in ABO gene expression regulation[J]. Blood&Genomics, 2019, 3(2): 101-107. DOI: 10.46701/APJBG.2019022019125
Citation: Xiaoya Yang, Gengyin Wang. Advances in ABO gene expression regulation[J]. Blood&Genomics, 2019, 3(2): 101-107. DOI: 10.46701/APJBG.2019022019125

Advances in ABO gene expression regulation

More Information
  • Available Online: 2021-06-29
  • The ABO blood group system is vital to blood transfusion and organ transplantation. ABO antigens are the most important of all blood group antigens in clinical practice, and are not only present in red blood cells and platelets, but also in most secretions and epithelial tissues. ABO antigens are known to undergo drastic changes during the development, differentiation, and maturation of normal cells. Profound changes have also been documented in pathological processes such as tumorigenesis. To elucidate the molecular basis of how ABO genes are controlled in cell type specific expressions, such as normal cell differentiation or in cancer cells lacking A/B antigens, it is essential to understand the regulatory mechanisms of ABO gene expression. In this review, current knowledge concerning the regulatory mechanisms of ABO gene expression was summarized.
  • Related Articles

    [1]Yuxuan Wu, Zou Xiang. The combination of DNA methyltransferase inhibitor therapy and immunotherapy for acute myeloid leukemia[J]. Blood&Genomics, 2021, 5(2): 97-106. DOI: 10.46701/BG.2021022021132
    [2]Qing Liu, Jiayan Ling, Qilong Song, Xiaodong Li, Chizhi Zhang, Mingzhong Xiao, Jie Huang, Shuxia Han, Ling Liu, Xiaoming Peng, Jie Tan, Yu Wang, Li Ouyang, Youyun Zhao, Jianhua Wu. Association between polymorphism of the cyclin E1 gene and susceptibility to hepatocellular carcinoma in Chinese Han population of Hubei[J]. Blood&Genomics, 2019, 3(2): 125-131. DOI: 10.46701/APJBG.2019022019118
    [3]Xiaofei Li, YuShiang Lin, Tingting Liu, Ye Zhang, Guangyan Zhuang, Tianhong Miao, Zhiyuan Xu. Serological and molecular analysis of ABO and Rh blood group chimeras[J]. Blood&Genomics, 2018, 2(4): 263-268. DOI: 10.46701/APJBG.2018042018137
    [4]Suliang Li, Yun Ye, Shengyu Wang, Jianjun Wang. Exosomal miR-375 promotes the activity of osteoblasts in prostate cancer[J]. Blood&Genomics, 2018, 2(4): 241-248. DOI: 10.46701/APJBG.2018042018129
    [5]Ziyi He, Qing Wang, Shaobin Chen, LinYu, Bitao Huang. Analysis of factors related to ELISA-HBsAg negative and HBV DNA positive blood donors[J]. Blood&Genomics, 2018, 2(4): 237-240. DOI: 10.46701/APJBG.2018042018126
    [6]Gradimir Misevic. ABO blood group system[J]. Blood&Genomics, 2018, 2(2): 71-84. DOI: 10.46701/APJBG.2018022018113
    [7]Yuping Chen, Tongmao Zhao. Application of a multiplex PCR genotyping assay of 31 red blood cell antigens for establishment of a panel of reference DNA in China[J]. Blood&Genomics, 2017, 1(4): 13-16. DOI: 10.46701/APJBG.2017042017055
    [8]Zhiyuan Xu, Yushiang Lin, Xiaofei Li, Haochun Chang, Daowang Fan, Yan Qiu, Tianhong Miao. The incidence and features of serological ABO subgroups among one million blood donors in Beijing[J]. Blood&Genomics, 2017, 1(2): 57-60. DOI: 10.46701/APJBG.20170217025
    [9]Zhiwei Liu, Zhen Cheng, Beixing Gao, Bing Sun. Consistency of ABO blood group phenotypes and genotypes in renal transplant patients[J]. Blood&Genomics, 2017, 1(1): 51-54. DOI: 10.46701/APJBG.20170116015
    [10]Junhua Hu, Zhiyang Nie, Jiwu Gong. Identification of Suspected ABO Subtypes by Genotyping Kits[J]. Blood&Genomics, 2017, 1(1): 43-45. DOI: 10.46701/APJBG.20170116006

Catalog

    Article Metrics

    Article views (1027) PDF downloads (773) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return